The first experience of using carboxyangiography in renal denervation in a patient with resistant arterial hypertension, chronic kidney disease and iodine contrast allergy

Traditionally an iodine-containing contrast agent is used for renal arteries angiography. However, patients with chronic kidney disease (CKD) and allergic reaction to iodine, despite infusion and desensitization therapy, have a very high risk of developing complications after procedure. We present a clinical case of successful and safe use of carboxyangiography for renal artery denervation in a patient with resistant arterial hypertension (HTN) in combination with type 2 diabetes mellitus and CKD against the background of an allergic reaction to iodine contrast agents in the form of an anaphylactoid reaction in anamnesis (angioedema). An alternative type of angiography allowed us to carry out successful endovascular treatment of HTN resulting in the achievement of target blood pressure levels without intervention-related complications at early- and long-term follow-up.

1. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T et al. Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012;380(9854):1649–1661. doi:10.1016/S0140-6736(12)61272-0

2. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions. JACC: Cardiovasc Interv. 2014;7(1):1–9. doi:10.1016/j.jcin.2013.06.016

3. Hossain MA, Costanzo E, Cosentino J, Patel C, Qaisar H, Singh V et al. Contrast-induced nephropathy: pathophysiology, risk factors, and prevention. Saudi J Kidney Dis Transpl. 2018;29(1):1–9. doi:10.4103/1319-2442.225199

4. Brown JR, DeVries JT, Piper WD, Robb JF, Hearne MJ, Ver Lee PM et al. Northern New England Cardiovascular Disease Study Group. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J. 2008;155(2):260–266. doi:10.1016/j.ahj.2007.10.007

5. Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. 2020;259:118379. doi:10.1016/j.lfs.2020.118379

6. Hawkins IF, Cho KJ, Caridi JG. Carbon dioxide in angiography to reduce the risk of contrast-induced nephropathy. Radiol Clin North Am. 2009;47(5):813–825. doi:10.1016/j.rcl.2009.07.002

7. Renton M, Hameed MA, Dasgupta I, Hoey ET, Freedman J, Ganeshan A. The use of carbon dioxide angiography for renal sympathetic denervation: a technical report. Br J Radiol. 2016; 89(1068):20160311. doi:10.1259/bjr.20160311

8. Hameed MA, Freedman JS, Watkin R, Ganeshan A, Dasgupta I. Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease. Clin Kidney J. 2017; 10(6):778–782. doi:10.1093/ckj/sfx066

9. Fujihara M, Kawasaki D, Shintani Y, Fukunaga M, Nakama T, Koshida R et al. CO2 Angiography Registry Investigators. Endovascular therapy by CO2 angiography to prevent contrastinduced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry. Catheter Cardiovasc Interv. 2015;85(5):870–7. doi:10.1002/ccd.25722

10. Prasad A, Ortiz-Lopez C, Khan A, Levin D, Kaye DM. Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature. Catheter Cardiovasc Interv. 2016;88(2):264–273. doi:10.1002/ccd.26466

11. Grossman PM, Ali SS, Aronow HD, Boros M, Nypaver TJ, Schreiber TL et al. Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Interv Cardiol. 2017;30(3):274–280. doi:10.1111/joic.12379

12. Nadolski GJ, Stavropoulos SW. Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations. J Vasc Surg. 2013;57(2):593–598. doi:10.1016/j.jvs.2012.10.009

13. Xia M, Liu T, Chen D, Huang Y. Efficacy and safety of renal denervation for hypertension in patients with chronic kidney disease: a meta-analysis. Int J Hyperthermia. 2021;38(1):732–742. doi:10.1080/02656736.2021.1916100